Acute decompensated heart failure - treatments and challenges -

Circulation Journal : Official Journal of the Japanese Circulation Society
Barry H Greenberg

Abstract

Acute decompensated heart failure (ADHF) is a major public health problem throughout the world and its importance is continuing to grow. This article reviews the epidemiology of ADHF and the profile of patients suffering from this condition. It describes factors used in assessing prognosis and presents treatment options. Although no currently available treatments have been shown to favorably affect long-term outcomes, there are a variety of strategies and approaches to management that are expected to reduce morbidity and mortality following discharge after ADHF hospitalization. In particular, the clinician is alerted to the need to identify factors that trigger decompensation as well as to optimize treatments for chronic heart failure. The importance of the transition from hospital to the outpatient setting is described. Particular attention should be focused on providing health education to the patient and their family at an appropriate level of medical literacy as well as ensuring early follow-up evaluation after hospital discharge.

References

Aug 1, 1991·The New England Journal of Medicine·UNKNOWN SOLVD InvestigatorsJay N Cohn
Jan 14, 1988·The New England Journal of Medicine·J N RubinU Elkayam
Sep 15, 1988·Annals of Internal Medicine·G A Ewy
Aug 1, 1985·The American Journal of Cardiology·H NakanoA Saito
Jun 15, 2000·The American Journal of Pathology·D LevineL M Schnapp
Aug 10, 2000·The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation·L La VecchiaR Ometto
Jun 2, 2001·The New England Journal of Medicine·M PackerUNKNOWN Carvedilol Prospective Randomized Cumulative Survival Study Group
Oct 2, 2001·International Journal of Cardiology·G F Mendez, M R Cowie
Mar 28, 2002·JAMA : the Journal of the American Medical Association·UNKNOWN Publication Committee for the VMAC Investigators (Vasodilatation in the Management of Acute CHF)
Mar 28, 2002·JAMA : the Journal of the American Medical Association·Michael S CuffeUNKNOWN Outcomes of a Prospective Trial of Intravenous Milrinone for Exacerbations of Chronic Heart Failure (OPTIME-CHF) Investigato
May 1, 2002·JAMA : the Journal of the American Medical Association·Anthony F Jerant
Jun 19, 2002·Circulation·Debra K Moser, Douglas L Mann
Jul 19, 2002·The New England Journal of Medicine·Alan S MaiselUNKNOWN Breathing Not Properly Multinational Study Investigators
Jul 26, 2002·Journal of Cardiac Failure·Stephen S GottliebHarlan M Krumholz
Mar 26, 2003·Journal of the American College of Cardiology·G Michael FelkerUNKNOWN OPTIME-CHF Investigators
Apr 23, 2004·Expert Opinion on Pharmacotherapy·Srinivas IyengarWilliam T Abraham
Apr 29, 2004·JAMA : the Journal of the American Medical Association·Mihai GheorghiadeUNKNOWN Acute and Chronic Therapeutic Impact of a Vasopressin Antagonist in Congestive Heart Failure (ACTIV in CHF) Investigators
Nov 10, 2004·The New England Journal of Medicine·Anne L TaylorUNKNOWN African-American Heart Failure Trial Investigators
Jan 29, 2005·Journal of Cardiovascular Pharmacology and Therapeutics·Uri ElkayamMahyar Derakhshani
Feb 3, 2005·JAMA : the Journal of the American Medical Association·Gregg C FonarowUNKNOWN ADHERE Scientific Advisory Committee, Study Group, and Investigators
Apr 6, 2005·Heart Failure Reviews·Gregg C FonarowUNKNOWN ADHERE Scientific Advisory Committee
Sep 27, 2005·The American Journal of Cardiology·Mihai Gheorghiade, Alexandre Mebazaa
Oct 18, 2005·The Journal of Clinical Hypertension·Randall E Williams
Jul 4, 2006·Physiological Reviews·Volker VallonHartmut Osswald
Sep 13, 2006·Circulation·Mihai GheorghiadeRobert O Bonow
Jun 6, 1931·The Journal of Physiology·F R Winton
Nov 9, 2006·JAMA : the Journal of the American Medical Association·Mihai GheorghiadeUNKNOWN OPTIMIZE-HF Investigators and Coordinators
Dec 30, 2006·Circulation·Wayne RosamondUNKNOWN American Heart Association Statistics Committee and Stroke Statistics Subcommittee
Feb 13, 2007·Journal of the American College of Cardiology·Maria Rosa CostanzoUNKNOWN UNLOAD Trial Investigators
May 8, 2007·European Journal of Heart Failure·Marco MetraUNKNOWN Heart Failure Association of the European Society of Cardiology

❮ Previous
Next ❯

Citations

Feb 20, 2014·Medical Science Monitor : International Medical Journal of Experimental and Clinical Research·Abdurrahman TasalEsmeray Acarturk
Sep 26, 2014·Circulation Journal : Official Journal of the Japanese Circulation Society·Tadafumi SugimotoMasaaki Ito
Mar 15, 2015·Journal of Telemedicine and Telecare·Riet DierckxAndrew L Clark
Sep 5, 2014·Critical Care Nursing Quarterly·Sara Paul, Amber Hice
Oct 11, 2013·Circulation. Heart Failure·Hani N SabbahDavid A Kass
Jun 13, 2012·Medizinische Klinik, Intensivmedizin und Notfallmedizin·U Janssens
Jul 19, 2019·Circulation Journal : Official Journal of the Japanese Circulation Society·Yoshihito AraoToyoaki Murohara
Dec 3, 2013·Circulation Journal : Official Journal of the Japanese Circulation Society·Julio NúñezJuan Sanchis
Aug 30, 2014·Circulation Journal : Official Journal of the Japanese Circulation Society·Domenico ScrutinioFabrizio Oliva
Aug 23, 2016·Circulation Journal : Official Journal of the Japanese Circulation Society·Barry Greenberg
Oct 15, 2014·Circulation Journal : Official Journal of the Japanese Circulation Society·Takayuki Inomata

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.